StreetAlpha.app
Home › Stocks › ADPT

Adaptive Biotechnologies Corp (ADPT)

Healthcare
$27.93
▼ −0.43%
LAST CLOSE · NOV 20

Adaptive Biotechnologies makes immune system based cancer tests and sells immune data to clinicians and drug developers. It last closed at $27.93 on Nov 20, down 0.43% on the day. The next earnings report for ADPT is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, ADPT reported EPS of $0.02 on revenue of $83.9M, with revenue down 10.7% from a year ago. Over its last 8 reports the stock moved an average of 10.3% the session after earnings. Over the last 12 months ADPT insiders bought $0 of stock on the open market and sold $131.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is ADPT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ADPT.

Key Stats

Last 12 months
Results
Revenue
$298.0M
+17.9% vs a year ago
Net income
−$70.5M
−23.7% margin
EPS (diluted)
−$0.45
Free cash flow
−$8.8M
−3.0% margin
Valuation
Market cap
$4.5B
161.9M shares
P/E
–
No P/E while losing money
Price to sales
15.2
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$75.6M
At Sep 30
Debt
$0
At Sep 30
Shareholder equity
$176.2M
Shares outstanding
161.9M
At Oct 30
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $154.3M$154.3MFY2021FY2022: $185.3M$185.3MFY2022FY2023: $170.3M$170.3MFY2023FY2024: $179.0M$179.0MFY2024FY2025: $277.0M$277.0MFY2025

From ADPT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
$0.02
Quarter ended Sep 2026
Year ago EPS
$0.06
−66.7% on a GAAP basis
Revenue
$83.9M
−10.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.22Dec '24Mar 2025: -$0.20Mar '25Jun 2025: -$0.17Jun '25Sep 2025: $0.06Sep '25Dec 2025: -$0.09Dec '25Mar 2026: -$0.13Mar '26Jun 2026: -$0.25Jun '26Sep 2026: $0.02Sep '26Latest $0.02
Revenue by quarter
Dec 2024: $47.5MDec '24Mar 2025: $52.4MMar '25Jun 2025: $58.9MJun '25Sep 2025: $94.0MSep '25Dec 2025: $71.7MDec '25Mar 2026: $70.9MMar '26Jun 2026: $71.6MJun '26Sep 2026: $83.9MSep '26Latest $83.9M
How ADPT moved after its last 8 reports
Average move the session after a report ±10.3%
Nov 4, 2026After the close+0.5%
Jul 29, 2026After the close+7.2%
May 5, 2026After the close+4.7%
Jan 12, 2026Time not announced+15.9%
Nov 5, 2025After the close−11.5%
Aug 5, 2025After the close+5.8%
May 1, 2025After the close+33.7%
Feb 11, 2025After the close−3.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on ADPTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on ADPT
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on ADPT

Technical Analysis

ADPT · as of the Nov 20 close · updated each morning
Uptrend

The stock is 0% above its 20 day and 2% above its 50 day average. It is 27% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 52). The nearest support is the 20 day average at $27.92, and the nearest resistance the Pivot R1 at $28.39.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 6.1%/day
Key levels
$32.2152 week high+15.3%
$29.05Swing high (Oct 28)+4.0%
$28.39Pivot R1+1.6%
$27.93Last close
$27.9220 day average−0.0%
$27.77Pivot−0.6%
$27.31Pivot S1−2.2%
$27.2950 day average−2.3%
$27.29Swing low (Nov 16)−2.3%
$25.49100 day average−8.7%
$20.35200 day average−27.1%
$12.0052 week low−57.0%
Indicators
RSI (14)51.55Middle of its rangeNeutral
MACD0.53Below its signal lineBearish
Stochastic44.1Middle of its rangeNeutral
ADX (14)17.3No clear trend
Williams %R-61.0Oversold below −80, overbought above −20Neutral
CCI (20)-9.5Oversold below −100, overbought above 100Neutral
Rate of change−0.2%Change over 10 sessionsBearish
ATR (14)$1.69Typical daily range, 6.1% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ADPT

What happened before

See how ADPT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow ADPT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How ADPT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for ADPTHow many large options trades hit ADPT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

ADPT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲187 buying vs 137 selling
  • ▲Held by funds +6.9 pts
  • ▲Funds holding +30
  • ▲Superinvestors: 5 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding335305+9.8%
In funds' top 1052+150.0%
Held by funds103.2%96.3%+6.9 pts
New / increased64 / 12346 / 109+20.6%
Reduced / sold out105 / 3288 / 42+5.4%
Put/call ratio0.00––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ADPT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

ADPT Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$131.7M80 sales · 11 insiders
74% of the selling was under pre-arranged trading plans.
2025-12 sold $6.2M2026-01 sold $3.7M2026-02 sold $3.1M2026-03 sold $32.8M2026-04 sold $7.5M2026-05 sold $41K2026-06 sold $7.5M2026-07 sold $24.0M2026-08 sold $19.1M2026-09 sold $3.3M2026-10 sold $7.5M2026-11 sold $3.7MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 13Julie RubinsteinPresident and COOSale plan35,228$29.73$1.0M
Nov 11Susan BobulskyChief Commercial Officer, MRDSale plan1,875$32.00$60K
Nov 10Julie RubinsteinPresident and COOSale plan23,762$29.82$709K
Nov 6Julie RubinsteinPresident and COOSale plan35,643$26.78$954K
Nov 3Julie RubinsteinPresident and COOSale plan35,643$26.06$929K
Oct 29Julie RubinsteinPresident and COOSale plan35,643$28.00$998K
Every insider buy and sale for ADPT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See ADPT insider trades →

From SEC Form 4 filings by ADPT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ADPT is in one of them and how their past ADPT trades turned out.

ADPT in the AI portfolios
Loading…

ADPT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ADPT in an article yet. Here's the latest on the wider market.

ADPT in the news

About Adaptive Biotechnologies

Adaptive Biotechnologies is a life sciences company based in Seattle, Washington. It uses sequencing and data analysis of the immune system to develop medical tests and products. Its main product, clonoSEQ, measures residual disease in patients with blood cancers and is sold to clinicians. It also runs testing for biopharmaceutical companies developing new drugs and licenses its immune system data to drug developers.

Headquarters
Seattle, WA
Founded
2009